Iranian Red Crescent Medical Journal

Published by: Kowsar

The Effect of a Single Intramuscular Injection of Cholecalciferol on the Serum Levels of Vitamin D, Adiponectin, Insulin Resistance, and Liver Function in Women with Non-Alcoholic Fatty Liver Disease (NAFLD): A Randomized, Controlled Clinical Trial

Sonia Mansourian Hosseini 1 , Soodabeh Aliashrafi 1 and Mehrangiz Ebrahimi-Mameghani 2 , *
Authors Information
1 Student Research Committee, Faculty of Nutrition and Food Science, Tabriz University of Medical Sciences, Tabriz, Iran
2 Nutrition Research Center, School of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran
Article information
  • Iranian Red Crescent Medical Journal: October 2018, 20 (10); e60746
  • Published Online: September 18, 2018
  • Article Type: Research Article
  • Received: August 22, 2017
  • Revised: December 1, 2017
  • Accepted: February 14, 2018
  • DOI: 10.5812/ircmj.60746

To Cite: Mansourian Hosseini S, Aliashrafi S, Ebrahimi-Mameghani M. The Effect of a Single Intramuscular Injection of Cholecalciferol on the Serum Levels of Vitamin D, Adiponectin, Insulin Resistance, and Liver Function in Women with Non-Alcoholic Fatty Liver Disease (NAFLD): A Randomized, Controlled Clinical Trial, Iran Red Crescent Med J. 2018 ; 20(10):e60746. doi: 10.5812/ircmj.60746.

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Foroughi M, Maghsoudi Z, Ghiasvand R, Iraj B, Askari G. Effect of vitamin D supplementation on C-reactive protein in patients with nonalcoholic fatty liver. Int J Prev Med. 2014;5(8):969-75. [PubMed: 25489444]. [PubMed Central: PMC4258669].
  • 2. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30. doi: 10.1210/jc.2011-0385. [PubMed: 21646368].
  • 3. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab. 2012;97(4):1153-8. doi: 10.1210/jc.2011-2601. [PubMed: 22442274].
  • 4. Pike JW, Meyer MB. Fundamentals of vitamin D hormone-regulated gene expression. J Steroid Biochem Mol Biol. 2014;144 Pt A:5-11. doi: 10.1016/j.jsbmb.2013.11.004. [PubMed: 24239506]. [PubMed Central: PMC4144817].
  • 5. Rhee EJ, Kim MK, Park SE, Park CY, Baek KH, Lee WY, et al. High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. Endocr J. 2013;60(6):743-52. doi: 10.1507/endocrj.EJ12-0387. [PubMed: 23411507].
  • 6. Musso G. Non-alcoholic fatty liver, adipose tissue, and the bone: A new triumvirate on the block. Endocrine. 2012;42(2):237-9. doi: 10.1007/s12020-012-9748-2. [PubMed: 22801991].
  • 7. Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, et al. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011;9:85. doi: 10.1186/1741-7015-9-85. [PubMed: 21749681]. [PubMed Central: PMC3148980].
  • 8. Wang X, Li W, Zhang Y, Yang Y, Qin G. Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis. Int J Clin Exp Med. 2015;8(10):17221-34. [PubMed: 26770315]. [PubMed Central: PMC4694215].
  • 9. Hashemi Kani A, Alavian SM, Esmaillzadeh A, Adibi P, Azadbakht L. Dietary quality indices and biochemical parameters among patients with non alcoholic fatty liver disease (NAFLD). Hepat Mon. 2013;13(7). e10943. doi: 10.5812/hepatmon.10943. [PubMed: 24065998]. [PubMed Central: PMC3776150].
  • 10. Kocot J, Dziemidok P, Kielczykowska M, Kurzepa J, Szczesniak G, Musik I. Is there any relationship between plasma 25-Hydroxyvitamin D(3), adipokine profiles and excessive body weight in type 2 diabetic patients? Int J Environ Res Public Health. 2017;15(1). doi: 10.3390/ijerph15010019. [PubMed: 29295491]. [PubMed Central: PMC5800119].
  • 11. Adolph TE, Grander C, Grabherr F, Tilg H. Adipokines and non-alcoholic fatty liver disease: Multiple interactions. Int J Mol Sci. 2017;18(8). doi: 10.3390/ijms18081649. [PubMed: 28758929]. [PubMed Central: PMC5578039].
  • 12. Gannage-Yared MH, Chedid R, Khalife S, Azzi E, Zoghbi F, Halaby G. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol. 2009;160(6):965-71. doi: 10.1530/EJE-08-0952. [PubMed: 19289535].
  • 13. Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: A multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012;8(3). e1002607. doi: 10.1371/journal.pgen.1002607. [PubMed: 22479202]. [PubMed Central: PMC3315470].
  • 14. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest. 2003;112(1):91-100. doi: 10.1172/JCI17797. [PubMed: 12840063]. [PubMed Central: PMC162288].
  • 15. Neyestani TR, Nikooyeh B, Alavi-Majd H, Shariatzadeh N, Kalayi A, Tayebinejad N, et al. Improvement of vitamin D status via daily intake of fortified yogurt drink either with or without extra calcium ameliorates systemic inflammatory biomarkers, including adipokines, in the subjects with type 2 diabetes. J Clin Endocrinol Metab. 2012;97(6):2005-11. doi: 10.1210/jc.2011-3465. [PubMed: 22442277].
  • 16. Baziar N, Jafarian K, Shadman Z, Qorbani M, Khoshniat Nikoo M, Abd Mishani M. Effect of therapeutic dose of vitamin d on serum adiponectin and glycemia in vitamin d-insufficient or deficient type 2 diabetic patients. Iran Red Crescent Med J. 2014;16(9). e21458. doi: 10.5812/ircmj.21458. [PubMed: 25593737]. [PubMed Central: PMC4270651].
  • 17. Belenchia AM, Tosh AK, Hillman LS, Peterson CA. Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: A randomized controlled trial. Am J Clin Nutr. 2013;97(4):774-81. doi: 10.3945/ajcn.112.050013. [PubMed: 23407306].
  • 18. Del Ben M, Polimeni L, Baratta F, Pastori D, Loffredo L, Angelico F. Modern approach to the clinical management of non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20(26):8341-50. doi: 10.3748/wjg.v20.i26.8341. [PubMed: 25024593]. [PubMed Central: PMC4093688].
  • 19. Ostad Rahimi AR, Mahbob SA, Abbas Alizadeh Farhanghi M, Vahed Jabarii M. [The effect of cholecalciferol injection on serum 25 hydroxy vitamin D and parathyroid hormone in obese and none obese reproductive age women]. Pharm Sci. 2009;15(1):9-16. Persian.
  • 20. Khan AH, Rohra DK, Saghir SA, Udani SK, Wood R, Jabbar A. Response of a single 'mega intramuscular dose' of vitamin D on serum 25OHD and parathyroid hormone levels. J Coll Physicians Surg Pak. 2012;22(4):207-12. [PubMed: 22482374].
  • 21. Aadahl M, Jorgensen T. Validation of a new self-report instrument for measuring physical activity. Med Sci Sports Exerc. 2003;35(7):1196-202. doi: 10.1249/01.MSS.0000074446.02192.14. [PubMed: 12840642].
  • 22. Einarsdottir K, Preen DB, Clay TD, Kiely L, Holman CD, Cohen LD. Effect of a single 'megadose' intramuscular vitamin D (600,000 IU) injection on vitamin D concentrations and bone mineral density following biliopancreatic diversion surgery. Obes Surg. 2010;20(6):732-7. doi: 10.1007/s11695-009-0024-3. [PubMed: 19949888].
  • 23. Cipriani C, Romagnoli E, Pepe J, Russo S, Carlucci L, Piemonte S, et al. Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: Implications for treatment and prophylaxis. J Clin Endocrinol Metab. 2013;98(7):2709-15. doi: 10.1210/jc.2013-1586. [PubMed: 23766519].
  • 24. Heshmat R, Tabatabaei-Malazy O, Abbaszadeh-Ahranjani S, Shahbazi S, Khooshehchin G, Bandarian F, et al. Effect of vitamin D on insulin resistance and anthropometric parameters in type 2 diabetes; a randomized double-blind clinical trial. Daru. 2012;20(1):10. doi: 10.1186/2008-2231-20-10. [PubMed: 23351271]. [PubMed Central: PMC3555787].
  • 25. Manco M. Insulin resistance and NAFLD: A dangerous liaison beyond the Genetics. Children (Basel). 2017;4(8). doi: 10.3390/children4080074. [PubMed: 28805745]. [PubMed Central: PMC5575596].
  • 26. Nakano T, Cheng YF, Lai CY, Hsu LW, Chang YC, Deng JY, et al. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol. 2011;55(2):415-25. doi: 10.1016/j.jhep.2010.11.028. [PubMed: 21184788].
  • 27. Mozaffari-Khosravi H, Hosseinzadeh-Shamsi-Anar M, Salami MA, Hadinedoushan H, Mozayan MR. Effects of a single post-partum injection of a high dose of vitamin D on glucose tolerance and insulin resistance in mothers with first-time gestational diabetes mellitus. Diabet Med. 2012;29(1):36-42. doi: 10.1111/j.1464-5491.2011.03473.x. [PubMed: 21977923].
  • 28. Sharifi N, Amani R, Hajiani E, Cheraghian B. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine. 2014;47(1):70-80. doi: 10.1007/s12020-014-0336-5. [PubMed: 24968737].
  • 29. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr. 2010;103(4):549-55. doi: 10.1017/S0007114509992017. [PubMed: 19781131].
  • 30. Adams LA, Lindor KD. Nonalcoholic fatty liver disease. Ann Epidemiol. 2007;17(11):863-9. doi: 10.1016/j.annepidem.2007.05.013. [PubMed: 17728149].
  • 31. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest. 2007;117(9):2621-37. doi: 10.1172/JCI31021. [PubMed: 17717599]. [PubMed Central: PMC1950456].
  • 32. Balmer ML, Joneli J, Schoepfer A, Stickel F, Thormann W, Dufour JF. Significance of serum adiponectin levels in patients with chronic liver disease. Clin Sci (Lond). 2010;119(10):431-6. doi: 10.1042/CS20100008. [PubMed: 20524936]. [PubMed Central: PMC2916712].
  • 33. Lee S, Lee DK, Choi E, Lee JW. Identification of a functional vitamin D response element in the murine Insig-2 promoter and its potential role in the differentiation of 3T3-L1 preadipocytes. Mol Endocrinol. 2005;19(2):399-408. doi: 10.1210/me.2004-0324. [PubMed: 15528275].
  • 34. Skaaby T, Husemoen LL, Borglykke A, Jorgensen T, Thuesen BH, Pisinger C, et al. Vitamin D status, liver enzymes, and incident liver disease and mortality: A general population study. Endocrine. 2014;47(1):213-20. doi: 10.1007/s12020-013-0107-8. [PubMed: 24272594].
  • 35. Barchetta I, Del Ben M, Angelico F, Di Martino M, Fraioli A, La Torre G, et al. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. BMC Med. 2016;14:92. doi: 10.1186/s12916-016-0638-y. [PubMed: 27353492]. [PubMed Central: PMC4926287].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments